XML 31 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements
3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements
12.
Fair Value Measurements

The Company’s financial instruments consist of its convertible notes and warrants.

There were no assets measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022. Liabilities measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022 were as follows:

 

 

Fair value measurements as of March 31, 2023

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

 

(in thousands)

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Convertible notes

 

 

 

 

 

 

 

 

4,350

 

 

 

4,350

 

Warrants

 

 

 

 

 

 

 

 

594

 

 

 

594

 

Total

 

$

 

 

$

 

 

$

4,944

 

 

$

4,944

 

 

 

Fair value measurements as of December 31, 2022

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

 

(in thousands)

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Convertible notes

 

 

 

 

 

 

 

 

4,270

 

 

 

4,270

 

Warrants

 

 

 

 

 

 

 

 

3,004

 

 

 

3,004

 

Total

 

$

 

 

$

 

 

$

7,274

 

 

$

7,274

 

 

During the three months ended March 31, 2023, there were no transfers between Level 1 and Level 2, nor into and out of Level 3.

The following tables summarize the activity for the Company Level 3 liabilities measured at fair value on a recurring basis for the three months ended March 31, 2023:

 

 

(in thousands)

 

Convertible Notes

 

Fair value at December 31, 2022

 

$

4,270

 

Issuance of convertible notes

 

 

 

Change in estimated fair value of financial instruments

 

 

80

 

Fair value at March 31, 2023

 

$

4,350

 

 

(in thousands)

 

Warrants

 

Fair value at December 31, 2022

 

$

3,004

 

Issuance of warrants

 

 

 

Change in estimated fair value of financial instruments

 

 

(2,410

)

Fair value at March 31, 2023

 

$

594

 

 

The following tables summarize the activity for the Company Level 3 liabilities measured at fair value on a recurring basis for the three months ended March 31, 2022:

 

(in thousands)

 

Convertible Notes

 

Fair value at December 31, 2021

 

 

 

Issuance of convertible notes

 

 

5,902

 

Change in estimated fair value of financial instruments

 

 

24

 

Conversion of convertible notes into Series A preferred stock

 

 

(5,926

)

Fair value at March 31, 2022

 

$

 

 

Convertible Notes

As further described in Note 10, the Company entered into several convertible note arrangements with certain investors during 2022. The Company recorded the liability related to the convertible notes at fair value and subsequently remeasured the instruments to fair value using level 3 fair value measurements. The fair value of the convertible notes was determined using a PWERM, in which the probability and timing of potential future events (such as a qualified equity financing prior to maturity) is considered in order to estimate the fair value of the convertible notes as of each valuation date. For the outstanding notes as of March 31, 2023, management determined the fair value of the convertible notes using the following significant unobservable inputs: (1) probability and timing of events, (2) expected future equity value of the underlying shares at the time of conversion, and (3) a discount rate of 21.05%.

The Company recorded a change in fair value adjustment of $0.08 million and $0.02 million in the condensed consolidated statement of operations and comprehensive loss for the three months ended March 31, 2023 and 2022, respectively.

Warrants

As further described in Note 11, on November 13, 2022, the Company issued an aggregate 92,296 warrants to purchase Class A Common Stock to various third-party investors in conjunction with the issuance of its November 2022 Convertible Notes. The Company recorded the liability related to the warrants at fair value and subsequently remeasured the instruments to fair value using level 3 fair value measurements. The fair value of the warrants was determined using a PWERM, in which the probability and timing of potential future events (such as a qualified equity financing prior to maturity) is considered in order to estimate the fair value of the warrants as of each valuation date. For the outstanding warrants as of March 31, 2023, management determined the fair value of the warrants using the following significant unobservable inputs: (1) probability and timing of events, (2) expected future equity value of the underlying shares at the time of conversion, and (3) a discount rate of 21.37%.

The Company recorded a change in fair value adjustment of $2.4 million and $0 million in the condensed consolidated statement of operations and comprehensive loss for the three months ended March 31, 2023 and 2022, respectively.